“…Since the initial report of biologically functional NMOFs/NCPs, interest in their biomedical applications has been steadily growing. − NMOFs and NCPs have been explored for a wide range of antitumor therapies, including chemotherapy, phototherapy, chemodynamic therapy (CDT), and combination therapy. , Furthermore, they contribute to achieving efficient imaging techniques including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and optical imaging (OI). ,− Compared to existing nanocarriers, NMOFs/NCPs offer several potential advantages for biomedical applications: (1) the ability to tailor their composition and structure enables the synthesis of NMOFs/NCPs with varying morphologies, sizes, and chemical properties; (2) high specific surface area and unique structures facilitate efficient encapsulation of a diverse spectrum of imaging and therapeutic agents; (3) the capability to modulate stimulus-triggered drug release and biodegradation under specific conditions underscores their potential to enhance biosafety and reduce adverse effects. (4) the utilization of (co)polymers, ligands, proteins, etc., provides the opportunity to design functional coatings that interact with the biological body. − These attributes have been applied in the development of multifunctional NMOFs and NCPs designed to mitigate nonspecific drug dispersion, prolong circulation time, minimize toxicity to normal tissues, enhance treatment effectiveness, and provide theranostic possibilities.…”